A 28-year-old primigravida from Delhi presents at 24 weeks of gestation for routine antenatal care. She is asymptomatic with no significant past medical history. Her BMI is 26 kg/m². Routine screening with 75 g oral glucose tolerance test (OGTT) shows fasting blood glucose 95 mg/dL, 1-hour 165 mg/dL, and 2-hour 145 mg/dL. What is the most appropriate next step in management?

Explanation

## Diagnosis and Management of Gestational Diabetes at 24 Weeks ### OGTT Interpretation (75 g, WHO Criteria) | Time Point | Diagnostic Threshold | This Patient | |---|---|---| | Fasting | ≥92 mg/dL | 95 mg/dL ✓ abnormal | | 1-hour | ≥180 mg/dL | 165 mg/dL (normal) | | 2-hour | ≥153 mg/dL | 145 mg/dL (normal) | **Key Point:** One abnormal value on 75 g OGTT is diagnostic of gestational diabetes mellitus (GDM) per WHO 2013 criteria adopted by ICMR and most Indian guidelines. ### Management Algorithm for Newly Diagnosed GDM ```mermaid flowchart TD A[GDM Diagnosed at 24 weeks]:::outcome --> B[Initiate Lifestyle Intervention]:::action B --> C[Medical Nutrition Therapy]:::action B --> D[Home Glucose Monitoring]:::action C --> E{Fasting glucose control?}:::decision D --> E E -->|Controlled| F[Continue monitoring, repeat OGTT at 28 weeks]:::action E -->|Uncontrolled| G[Start Insulin/Metformin]:::action F --> H{Persistent elevation?}:::decision H -->|Yes| G H -->|No| I[Continue MNT + monitoring]:::action ``` **High-Yield:** First-line management of GDM is always medical nutrition therapy (MNT) and lifestyle modification, NOT immediate pharmacotherapy. Insulin is reserved for those who fail dietary control (fasting glucose >95 mg/dL or 2-hour postprandial >120 mg/dL on home monitoring for ≥2 weeks). ### Why MNT First? 1. **Efficacy:** 80–90% of women achieve glycemic control with diet and exercise alone. 2. **Safety:** No teratogenic risk; avoids unnecessary medication exposure. 3. **Guideline-based:** ACOG, FIGO, and ICMR all recommend MNT as first-line. **Clinical Pearl:** The 1-hour value of 165 mg/dL, while not diagnostic on its own, suggests mild hyperglycemia and warrants close monitoring. Repeat OGTT at 28 weeks is standard practice to assess progression and confirm need for pharmacotherapy. **Warning:** Do NOT start insulin immediately based on one elevated fasting value. A trial of MNT for 2 weeks with home glucose monitoring is mandatory before escalating to medication. [cite:ICMR GDM Guidelines 2018, ACOG Practice Bulletin 190]